These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 34805996)

  • 21. Nigral volumetric and microstructural measures in individuals with scans without evidence of dopaminergic deficit.
    Langley J; Hwang KS; Hu XP; Huddleston DE
    Front Neurosci; 2022; 16():1048945. PubMed ID: 36507343
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aberrant nigral diffusion in Parkinson's disease: A longitudinal diffusion tensor imaging study.
    Loane C; Politis M; Kefalopoulou Z; Valle-Guzman N; Paul G; Widner H; Foltynie T; Barker RA; Piccini P
    Mov Disord; 2016 Jul; 31(7):1020-6. PubMed ID: 27104232
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of striatonigral connectivity using probabilistic tractography in Parkinson's disease.
    Theisen F; Leda R; Pozorski V; Oh JM; Adluru N; Wong R; Okonkwo O; Dean DC; Bendlin BB; Johnson SC; Alexander AL; Gallagher CL
    Neuroimage Clin; 2017; 16():557-563. PubMed ID: 28971007
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Longitudinal changes in free-water within the substantia nigra of Parkinson's disease.
    Ofori E; Pasternak O; Planetta PJ; Li H; Burciu RG; Snyder AF; Lai S; Okun MS; Vaillancourt DE
    Brain; 2015 Aug; 138(Pt 8):2322-31. PubMed ID: 25981960
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decreased serum ceruloplasmin levels characteristically aggravate nigral iron deposition in Parkinson's disease.
    Jin L; Wang J; Zhao L; Jin H; Fei G; Zhang Y; Zeng M; Zhong C
    Brain; 2011 Jan; 134(Pt 1):50-8. PubMed ID: 21109502
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diffusion tensor imaging of the substantia nigra in Parkinson's disease revisited.
    Langley J; Huddleston DE; Merritt M; Chen X; McMurray R; Silver M; Factor SA; Hu X
    Hum Brain Mapp; 2016 Jul; 37(7):2547-56. PubMed ID: 27029026
    [TBL] [Abstract][Full Text] [Related]  

  • 27. T1-weighted MRI shows stage-dependent substantia nigra signal loss in Parkinson's disease.
    Schwarz ST; Rittman T; Gontu V; Morgan PS; Bajaj N; Auer DP
    Mov Disord; 2011 Aug; 26(9):1633-8. PubMed ID: 21491489
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo imaging of neuromelanin in Parkinson's disease using 18F-AV-1451 PET.
    Hansen AK; Knudsen K; Lillethorup TP; Landau AM; Parbo P; Fedorova T; Audrain H; Bender D; Østergaard K; Brooks DJ; Borghammer P
    Brain; 2016 Jul; 139(Pt 7):2039-49. PubMed ID: 27190023
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alterations of the nigrostriatal pathway in a 6-OHDA rat model of Parkinson's disease evaluated with multimodal MRI.
    Perlbarg V; Lambert J; Butler B; Felfli M; Valabrègue R; Privat AL; Lehéricy S; Petiet A
    PLoS One; 2018; 13(9):e0202597. PubMed ID: 30188909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Automated Assessment of the Substantia Nigra Pars Compacta in Parkinson's Disease: A Diffusion Tensor Imaging Study.
    Bergsland N; Pelizzari L; Laganá MM; Di Tella S; Rossetto F; Nemni R; Clerici M; Baglio F
    J Pers Med; 2021 Nov; 11(11):. PubMed ID: 34834587
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HFE H63D Limits Nigral Vulnerability to Paraquat in Agricultural Workers.
    Wang EW; Trojano ML; Lewis MM; Du G; Chen H; Brown GL; Jellen LC; Song I; Neely E; Kong L; Connor JR; Huang X
    Toxicol Sci; 2021 Apr; 181(1):47-57. PubMed ID: 33739421
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structural Imaging in Parkinson's Disease: New Developments.
    Prange S; Metereau E; Thobois S
    Curr Neurol Neurosci Rep; 2019 Jun; 19(8):50. PubMed ID: 31214847
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nigral iron deposition occurs across motor phenotypes of Parkinson's disease.
    Jin L; Wang J; Jin H; Fei G; Zhang Y; Chen W; Zhao L; Zhao N; Sun X; Zeng M; Zhong C
    Eur J Neurol; 2012 Jul; 19(7):969-76. PubMed ID: 22288465
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of age-related microstructural changes in locus coeruleus and substantia nigra pars compacta.
    Langley J; Hussain S; Flores JJ; Bennett IJ; Hu X
    Neurobiol Aging; 2020 Mar; 87():89-97. PubMed ID: 31870645
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined Application of Quantitative Susceptibility Mapping and Diffusion Kurtosis Imaging Techniques to Investigate the Effect of Iron Deposition on Microstructural Changes in the Brain in Parkinson's Disease.
    Yang L; Cheng Y; Sun Y; Xuan Y; Niu J; Guan J; Rong Y; Jia Y; Zhuang Z; Yan G; Wu R
    Front Aging Neurosci; 2022; 14():792778. PubMed ID: 35370619
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Choroidal Thickness Correlates with Clinical and Imaging Metrics of Parkinson's Disease: A Pilot Study.
    Brown GL; Camacci ML; Kim SD; Grillo S; Nguyen JV; Brown DA; Ullah SP; Lewis MM; Du G; Kong L; Sundstrom JM; Huang X; Bowie EM
    J Parkinsons Dis; 2021; 11(4):1857-1868. PubMed ID: 34275909
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
    Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
    Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disease duration and the integrity of the nigrostriatal system in Parkinson's disease.
    Kordower JH; Olanow CW; Dodiya HB; Chu Y; Beach TG; Adler CH; Halliday GM; Bartus RT
    Brain; 2013 Aug; 136(Pt 8):2419-31. PubMed ID: 23884810
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diffusion tensor and restriction spectrum imaging reflect different aspects of neurodegeneration in Parkinson's disease.
    Hope TR; Selnes P; Rektorová I; Anderkova L; Nemcova-Elfmarkova N; Balážová Z; Dale A; Bjørnerud A; Fladby T
    PLoS One; 2019; 14(5):e0217922. PubMed ID: 31150514
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Imaging brain iron and diffusion patterns: a follow-up study of Parkinson's disease in the initial stages.
    Rossi ME; Ruottinen H; Saunamäki T; Elovaara I; Dastidar P
    Acad Radiol; 2014 Jan; 21(1):64-71. PubMed ID: 24331266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.